This ketamine study looks at four adolescent cases (aged 14–19), each with a variety of comorbid diagnoses including treatment-resistant depression, bipolar disorder, eating disorders, anxiety, panic, and trauma-related symptoms.

Their courses varied, but each had symptomatic and functional improvements, and the ketamine treatment was well-tolerated.